Supriya Lifescience Limited (BOM:543434)
India · Delayed Price · Currency is INR 805.00
-7.65 (-0.94%)
At close: Aug 21, 2026
Supriya Lifescience Market Cap
Supriya Lifescience has a market cap or net worth of 64.82 billion as of August 21, 2026. Its market cap has increased by 18.21% in one year.
Market Cap
64.82B
Enterprise Value
64.09B
Revenue
8.73B
Ranking
n/a
PE Ratio
32.68
Stock Price
805.00
ChartMarket Cap Chart
Since December 28, 2021, Supriya Lifescience's market cap has increased from 31.46B to 64.82B, an increase of 106.08%. That is a compound annual growth rate of 16.83%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 21, 2026 | 64.82B | 7.18% |
| Dec 31, 2025 | 60.48B | 1.58% |
| Dec 31, 2024 | 59.54B | 135.04% |
| Dec 29, 2023 | 25.33B | 33.91% |
| Dec 30, 2022 | 18.92B | -51.41% |
| Dec 31, 2021 | 38.93B | 23.76% |
| Dec 28, 2021 | 31.46B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| CORONA Remedies | 131.04B |
| Viyash Scientific | 120.57B |
| Procter & Gamble Health | 96.85B |
| Sanofi India | 77.11B |
| Bliss GVS Pharma | 61.86B |
| FDC Limited | 56.69B |
| Morepen Laboratories | 52.60B |
| Gufic Biosciences | 43.41B |